Alzheimer Disease News

• Hearing, Vision Loss Combo a Colossal Risk for Cognitive Decline Seniors with hearing or vision loss are at significant risk of cognitive decline, but the risk skyrockets in individuals with both.
  Medscape Medical News, May 23, 2022
• A Cup of Cranberries a Day Tied to Better Memory Consuming the equivalent of one cup of cranberries daily may improve memory by increasing blood flow to key areas of the brain that support cognition, new research suggests.
  Medscape Medical News, May 20, 2022
• Many Americans Missing an Opportunity to Prevent Dementia Nearly half of all US adults aged 45 and older have modifiable risk factors for Alzheimer's and related dementia, including high blood pressure, low levels of physical activity, and obesity.
  Medscape Medical News, May 20, 2022
• A Computerized Test May Help Detect Cognitive Impairment Results correlated with Alzheimer’s prone regions on MRI .
  First Look, May 12, 2022
• Alcohol Use Disorder and the Risk of Neurodegenerative Diseases Alcohol use disorder is associated with a higher risk of Alzheimer’s disease and Parkinson’s disease, as demonstrated in this retrospective cohort study.
  First Look, May 12, 2022
• Knowing How the Brain Reacts to Smells May Help Fight Disease Neuroscientists use mathematical models to reproduce how the brain processes smell.
  WebMD Health News, May 11, 2022
• High MVA Injury Rate in Early-Onset Dementia a Cause for Concern Individuals diagnosed with young-onset dementia have an alarmingly high risk of serious injury because of motor vehicle accidents -- both as pedestrians and drivers.
  Medscape Medical News, May 10, 2022
• Periodontitis May Be Linked With Systemic Diseases Periodontitis may be associated with Alzheimer's disease and other chronic disorders, according to epidemiologic studies. The data suggest the importance of oral health for overall health.
  Medscape Medical News, May 09, 2022
• Neurology, Psychiatry Studies Overlook Sex as a Variable A survey of more than 3000 neurology and psychiatry studies found that the vast majority failed to use participants' sex as a variable for determining gender-based differences.
  Medscape Medical News, May 09, 2022
• ESOC 2022 'Brain Age' Gap Predicts Post-Stroke Outcomes Patients with a higher relative brain age relative to their chronological age had far worse outcomes after stroke, highlighting a biomarker that could be used to guide post-stroke care.
  Medscape Medical News, May 05, 2022
• Best Antioxidants to Prevent Age-Related Dementia Identified? The most important antioxidants for brain protection may be the carotenoids lutein+zeaxanthin and beta-cryptoxanthin, new research suggests.
  Medscape Medical News, May 05, 2022
• Using MRI to Track Cerebral Damage in Multiple Sclerosis Data on repair or progression in normal-appearing brain tissue on conventional MRI.
  First Look, May 05, 2022
• Lipid Measurements: Noninvasive Biomarkers for Alzheimer Disease? Changes in lipid metabolism may be associated with brain volumn and dementia risk.
  First Look, May 05, 2022
• Residential Green Space Linked to Better Cognitive Function Residential green space versus non-exposure is associated with significantly higher cognitive function, a finding that may be explained by less depression.
  Medscape Medical News, May 05, 2022
• Alert FDA Clears Diagnostic Test for Early Alzheimer's The US Food and Drug Administration has cleared the first in vitro diagnostic test for early detection of Alzheimer's disease.
  Medscape Medical News, May 04, 2022
• Depression Biomarkers: Which Ones Matter Most? A comprehensive meta-analysis shows multiple biomarkers associated with unipolar depression, supporting a multifactorial pathogenesis of the disorder.
  Medscape Medical News, May 03, 2022
• Moderna Plans to Build Vaccine Facility in Quebec Moderna Inc said it plans to build an mRNA vaccine manufacturing facility in Quebec province as part of the COVID-19 vaccine maker's 10-year partnership with the Canadian government to prepare for future pandemics.
  Reuters Health Information, April 29, 2022
• New Blood Biomarker to Detect Early Dementia? A unique ratio of metabolites reliably distinguished blood samples of early-stage Alzheimer's patients from controls.
  Medscape Medical News, April 28, 2022
• Genetic Alterations Lead to Diverse Cellular Effects in AD Investigators report data on genetic alterations that result in altered profiles within neurons and glia in patients with Alzheimer's disease (AD).
  First Look, April 28, 2022
• TBI, Even Without Loss of Consciousness, May Up Dementia Risk Traumatic brain injury even without loss of consciousness may be an important risk factor for late-life cognitive impairment, new research suggests.
  Medscape Medical News, April 28, 2022